Pharmaceuticals, Biotechnology and Life Sciences
Clinically relevant reductions in liver fat content, insulin resistance and fibroinflammation markers observed with AXA1125 along with favorable tolerability, supporting…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Axcella Health (Nasdaq: AXLA), a biotechnology company pioneering the research and development of novel multifactorial interventions to address…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/AXAcandidates?src=hash” target=”_blank”gt;#AXAcandidateslt;/agt;–Axcella Health, a biotechnology company pioneering the research and development of novel multifactorial interventions to address…
CAMBRIDGE, Mass.–(BUSINESS WIRE)—-Axcella Health, a biotechnology company pioneering the research and development of novel multifactorial interventions to address dysregulated metabolism…